Get started
AbbVie, Inc.AbbVie, Inc.AbbVie, Inc.

AbbVie, Inc.

No trades
See on Supercharts
Overview Financials News Ideas Discussions Technicals Forecast Seasonals
Bonds

ABBVCL bonds

Below is the list of AbbVie, Inc. corporate bonds. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol
YTM %
Volume
Price %
Coupon %
Maturity date
Outstanding amt
Face value
Min denom amt
Issuer
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
—3.77 M89.04%4.40%2042-11-062.6 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
—26 K76.04%4.75%2045-03-1553.51 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
—0128.71%4.85%2044-06-15100 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
—1.24 M103.36%4.88%2030-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
—10.03 M96.66%3.20%2029-11-215.44 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4.40%2042-11-061.1 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
—16 K89.58%4.55%2035-03-15107.65 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
—26 K90.47%3.20%2029-11-2162.52 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
—0126.76%4.75%2045-03-155 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
—13.15 M101.16%4.80%2027-03-152.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
—0123.74%4.55%2035-03-151 K USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
—2.89 M93.04%4.85%2044-06-151.01 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
—0121.31%4.25%2049-11-214.95 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
—5.73 M102.68%4.80%2029-03-152.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
—10.53 M103.04%5.20%2035-03-151 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
—640 K98.97%5.35%2044-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
—534 K91.49%4.88%2048-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
—690 K91.39%4.63%2042-10-01389.22 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
—8.78 M98.80%2.95%2026-11-213.99 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
—705 K97.98%5.50%2064-03-151.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
—7.85 M101.05%4.25%2028-11-141.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
—248 K91.40%4.75%2045-03-15827.09 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
—16 K77.52%4.85%2044-06-1565.23 M USD1,000.00 USD2,000.00 USDAllergan Funding SCS
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
—8.59 M82.76%4.25%2049-11-215.75 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
—1.42 M97.76%5.40%2054-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
—0111.17%2.95%2026-11-219.24 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
—12 K77.91%4.63%2042-10-0167.49 M USD1,000.00 USD2,000.00 USDActavis, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
—9.94 M100.18%5.60%2055-03-15750 M USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
—4.57 M98.46%4.55%2035-03-151.68 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
—10.8 M88.90%4.05%2039-11-214 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
—555 K103.66%4.95%2031-03-152 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
—6.01 M101.81%4.65%2028-03-151.25 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
—9.71 M102.71%5.05%2034-03-153 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
—090.66%2.63%2028-11-1572.11 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
—094.93%4.30%2036-05-141 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
—086.65%4.45%2046-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
—099.32%3.20%2026-05-142 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
—093.96%2.13%2029-06-0136.46 M EUR1,000.00 EUR100,000.00 EURAllergan Funding SCS
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
—097.88%2.13%2029-06-01506.09 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
—097.31%4.50%2035-05-142.5 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
—098.71%2.13%2028-11-17750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
—090.42%1.25%2031-11-18650 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
—090.19%4.70%2045-05-142.7 B USD1,000.00 USD2,000.00 USDAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
—096.67%0.75%2027-11-18750 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
—0100.23%2.63%2028-11-15427.79 M EUR1,000.00 EUR100,000.00 EURAbbVie, Inc.